FDA.reportPublic FDA data

everolimus 7.5 MG Oral Tablet

RxCUI
1119400
RxNorm name
everolimus 7.5 MG Oral Tablet
Display name
everolimus 7.5 MG Oral Tablet
Full name
everolimus 7.5 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EverolimusEVEROLIMUSHikma Pharmaceuticals USA Inc.5aaf2fb7-93f6-40d6-941a-9583a3794ce72026-08-14Warnings, Adverse reactionsExact identifier
rxcui: 1119400
EverolimusEVEROLIMUSTeva Pharmaceuticals USA, Inc.e3bca36b-29ed-4a2b-a1be-a57b6af805f62026-06-29Warnings, Adverse reactionsExact identifier
rxcui: 1119400
TORPENZEVEROLIMUSUpsher-Smith Laboratories, LLC4c0075dd-a0a8-4dc4-be32-1be8383fbbdc2026-06-10Warnings, Adverse reactionsExact identifier
rxcui: 1119400
AfinitorEVEROLIMUSNovartis Pharmaceuticals Corporation2150f73a-179b-4afc-b8ce-67c85cc72f042026-06-01Warnings, Adverse reactionsExact identifier
rxcui: 1119400
YulithiraEVEROLIMUSCivicaScript, LLC5e325efa-8ae6-4dac-b59b-d7c74c73186c2026-03-31Warnings, Adverse reactionsExact identifier
rxcui: 1119400
everolimusEVEROLIMUSNovugen Pharma (USA) LLC.67e62e26-448d-46ec-b5a1-00dc1b5e26c62026-03-10Warnings, Adverse reactionsExact identifier
rxcui: 1119400
EverolimusEVEROLIMUSBreckenridge Pharmaceutical, Inc.01f7b5fb-be0d-4adf-acd2-6899018de9662025-09-05Warnings, Adverse reactionsExact identifier
rxcui: 1119400
EVEROLIMUSEVEROLIMUSBiocon Pharma Inc.5fb55800-f322-6bb6-9dde-622925ef28bd2025-03-21Warnings, Adverse reactionsExact identifier
rxcui: 1119400
EVEROLIMUSEVEROLIMUSNorthStar RxLLC5cfca904-b75c-5a39-8cb9-b99bb421bceb2024-08-02Warnings, Adverse reactionsExact identifier
rxcui: 1119400
EverolimusEVEROLIMUSNatco Pharma Limitede3dbbc24-7e55-4069-a305-e2cded2db6412023-06-08Warnings, Adverse reactionsExact identifier
rxcui: 1119400

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 10 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2150f73a-179b-4afc-b8ce-67c85cc72f04everolimus 7.5 MG Oral Tablet [PSN] · everolimus 7.5 MG Oral Tablet [SCD]266These highlights do not include all the information needed to use AFINITOR/AFINITOR DISPERZ safely and effectively. See full prescribing information for AFINITOR/AFINITOR DISPERZ. AFINITOR ® (everolimus) tablets, for oral use AFINITOR DISPERZ ® (everolimus tablets for oral suspension) Initial U.S. Approval: 200920260212
45d54974-3fc4-4237-a2fa-3158ca1a8105everolimus 7.5 MG Oral Tablet [PSN] · everolimus 7.5 MG Oral Tablet [SCD]223These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 200920260116
01f7b5fb-be0d-4adf-acd2-6899018de966everolimus 7.5 MG Oral Tablet [PSN] · everolimus 7.5 MG Oral Tablet [SCD]220These highlights do not include all the information needed to use EVEROLIMUS TABLETS/EVEROLIMUS TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EVEROLIMUS TABLETS/EVEROLIMUS TABLETS FOR ORAL SUSPENSION. EVEROLIMUS tablets, for oral use EVEROLIMUS tablets for oral suspension Initial U.S. Approval: 200920250905
4c0075dd-a0a8-4dc4-be32-1be8383fbbdceverolimus 7.5 MG Oral Tablet [PSN] · everolimus 7.5 MG Oral Tablet [SCD]211These highlights do not include all the information needed to use TORPENZ TABLETS safely and effectively. See full prescribing information for TORPENZ TABLETS. TORPENZ™ (everolimus) tablets, for oral use Initial U.S. Approval: 200920260215
5fb55800-f322-6bb6-9dde-622925ef28bdeverolimus 7.5 MG Oral Tablet [PSN] · everolimus 7.5 MG Oral Tablet [SCD]211These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 200920250321
e3bca36b-29ed-4a2b-a1be-a57b6af805f6everolimus 7.5 MG Oral Tablet [PSN] · everolimus 7.5 MG Oral Tablet [SCD]210These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS . EVEROLIMUS tablets, for oral use Initial U.S. Approval: 200920260309
5aaf2fb7-93f6-40d6-941a-9583a3794ce7everolimus 7.5 MG Oral Tablet [PSN] · everolimus 7.5 MG Oral Tablet [SCD]29These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 200920240423
e3dbbc24-7e55-4069-a305-e2cded2db641everolimus 7.5 MG Oral Tablet [PSN] · everolimus 7.5 MG Oral Tablet [SCD]27These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 200920230608
5cfca904-b75c-5a39-8cb9-b99bb421bcebeverolimus 7.5 MG Oral Tablet [PSN] · everolimus 7.5 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use EVEROLIMUS safely and effectively. See full prescribing information for EVEROLIMUS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 200920240802
67e62e26-448d-46ec-b5a1-00dc1b5e26c6everolimus 7.5 MG Oral Tablet [PSN] · everolimus 7.5 MG Oral Tablet [SCD]21These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 200920260310